Literature DB >> 21361736

Drug misuse and diversion in adults prescribed anxiolytics and sedatives.

Megan E McLarnon1, Tracy L Monaghan, Sherry H Stewart, Sean P Barrett.   

Abstract

STUDY
OBJECTIVE: To identify patterns of misuse and diversion of anxiolytic and sedative drugs among a sample of adults prescribed these drugs.
DESIGN: Cross-sectional study.
SETTING: University research center in Canada. PARTICIPANTS: Sixty-seven adults (aged 19-61 yrs) who had current prescriptions for anxiolytic or sedative drugs. INTERVENTION: Face-to-face interviews and questionnaires were used to gather information on demographics as well as variables relating to drug misuse and diversion such as personality dimensions, psychiatric symptoms, and other substance use.
MEASUREMENTS AND MAIN RESULTS: Of the 67 participants, 36 (54%) reported misusing their drugs on at least one occasion, and 35 (52%) reported diverting their drugs at least once. A variety of forms of anxiolytic or sedative misuse were reported, including exceeding the recommended dosage (28 participants [42%]), deliberately using the drug with alcohol or another drug (27 [40%]), or taking it by an alternate route of administration (5 [7%]). Misuse and diversion were associated with a history of substance use and substance-related problems, as well as personality characteristics relating to impulsivity and hopelessness. Diversion was also associated with an increased likelihood of having taken any psychoactive prescription drug without having a valid prescription for it.
CONCLUSION: A variety of forms of drug misuse and diversion occurred among this population of adults who were prescribed anxiolytics or sedatives. Likelihood of engaging in misuse or diversion was associated with other substance use, substance use disorders, and personality characteristics. Despite the modest sample size and cross-sectional design, this study identified substantial heterogeneity in prescription anxiolytic and sedative misuse, suggesting that the use of clearly defined operational criteria will be essential in future efforts to further characterize this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21361736     DOI: 10.1592/phco.31.3.262

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

1.  Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US.

Authors:  Ty S Schepis; Christian J Teter; Linda Simoni-Wastila; Sean Esteban McCabe
Journal:  Addict Behav       Date:  2018-06-12       Impact factor: 3.913

2.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

3.  Perceived Stress, Alexithymia, and Psychological Health as Predictors of Sedative Abuse.

Authors:  Nader Rajabi Gilan; Ali Zakiei; Sohyla Reshadat; Saeid Komasi; Seyed Ramin Ghasemi
Journal:  Korean J Fam Med       Date:  2015-09-18

4.  Validation of telephone-based behavioral assessments in aging services clients.

Authors:  Yeates Conwell; Adam Simning; Nicole Driffill; Yinglin Xia; Xin Tu; Susan P Messing; David Oslin
Journal:  Int Psychogeriatr       Date:  2017-09-20       Impact factor: 3.878

5.  Big Five personality traits and illicit drug use: Specificity in trait-drug associations.

Authors:  Genevieve F Dash; Nicholas G Martin; Wendy S Slutske
Journal:  Psychol Addict Behav       Date:  2021-11-11

6.  Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents' use and substance use disorder symptoms in adulthood.

Authors:  Sean Esteban McCabe; Philip Veliz; Carol J Boyd; John E Schulenberg
Journal:  Addict Behav       Date:  2016-08-15       Impact factor: 3.913

7.  Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use.

Authors:  Jason D Wright; Jacob C Cogan; Yongmei Huang; Ana I Tergas; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Allison Gockley; Melissa Accordino; Alexander Melamed; Dawn L Hershman
Journal:  JAMA Netw Open       Date:  2021-06-01

8.  Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis.

Authors:  Jack Cunliffe; David Décary-Hêtu; Thomas A Pollak
Journal:  Int J Drug Policy       Date:  2019-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.